BUSINESS COMBINATION AGREEMENT by and among VOYAGER ACQUISITION CORP., VERAXA BIOTECH AG and Oliver Baumann dated as of April 22, 2025Business Combination Agreement • April 23rd, 2025 • Voyager Acquisition Corp./Cayman Islands • Blank checks • New York
This Business Combination Agreement (this “Agreement”), dated as of April 22, 2025 (the “Signing Date”), is made and entered into by and among Voyager Acquisition Corp., an exempted company limited by shares incorporated under the laws of the Cayman Islands (“SPAC”), Veraxa Biotech AG, a public limited company organized under the Laws of Switzerland (the “Company”), and Oliver Baumann, an individual, solely in his capacity as representative for the Company Shareholders (the “Shareholder Representative”).
BUSINESS COMBINATION AGREEMENTBusiness Combination Agreement • April 13th, 2021 • Delaware